₨ 430
Empaa L 25/5 mg tablet is a combination medication that contains two active ingredients, empagliflozin + linagliptin. Empagliflozin belongs to a class of drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, while linagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. Together, these drugs work to lower blood sugar levels in people with type 2 diabetes.
Empaa L 25/5 mg tablet is a round, biconvex, pink film-coated tablet that contains 25mg of empagliflozin and 5mg of linagliptin.
Uses and Benefits: Empaa L 25/5 mg tablet is used for the treatment of type 2 diabetes in adults. It works by helping the kidneys to remove excess glucose from the body through urine, and by increasing the production of insulin in response to meals. This medication helps to lower blood sugar levels and may also reduce the risk of cardiovascular events in people with type 2 diabetes.
Empaa L 25/5 mg tablet may cause some side effects in some people. These side effects include:
Empaa L 25/5 mg tablet should be used with caution in the following conditions:
It is important to monitor kidney function regularly while taking this medication, as it may cause acute kidney injury. Additionally, it is important to stay well-hydrated while taking this medication, as it may cause dehydration.
In conclusion, Empaa L 25/5 mg tablet is a combination medication used for the treatment of type 2 diabetes in adults. It works by lowering blood sugar levels and may also reduce the risk of cardiovascular events. Empaa L 25/5 mg tablet may cause some side effects in some people, and it should be used with caution in certain medical conditions. It is important to consult a healthcare professional before taking any medication to ensure that it is safe and appropriate for you.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
These medicines contain the same salt as Empaa L 25/5 mg Tablet (EMPAGLIFLOZIN + Linagliptin 25/5mg), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Linvesta Emp 25/5mg Tablet | Wilshire Laboratories | 14 tablets | Rs 558 |
| Erlina 25/5mg Tablet | Pharmevo | 14 tablets | Rs 602 |
| Glem Lin 25/5mg Tablet | Nabiqasim Industries | 14 tablets | Rs 755 |
| Xenglu Lin 25/5mg Tablet | Hilton Pharma | 14 tablets | Rs 794 |
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Glem Lin 10/5mg Tablet | Nabiqasim Industries | 10/5mg | Rs 360 |
| Linvesta Emp 10mg/5mg Tablet | Wilshire Laboratories | 10mg/5mg | Rs 377 |
| Emsyn Lee 5/10mg Tablet | Searle Company | 5/10mg | Rs 453 |
| Empagen L 5/10mg Tablet | Ferozsons Laboratories | 5/10mg | Rs 454 |
You must be logged in to post a review.
No account yet?
Create an Account
Reviews
Clear filtersThere are no reviews yet.